Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF

Documenti analoghi

• Outcomes Among Drug Refractory Patients With Atrial Fibrillation (AF) and Concomitant Heart Failure With Preserved Ejection Fraction (HFpEF) Treated With Catheter Ablation Versus Antiarrhythmic Drugs
  di: Abhishek J. Deshmukh, et al.
  Pubblicazione: (2026)
• Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges
  di: Sanjeev Saksena, et al.
  Pubblicazione: (2025)
• The Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence and Long‐Term Clinical Outcomes in HFrEF Patients Undergoing Cryoballoon Ablation: A New Frontier Beyond Diabetes and Heart Failure
  di: Elif Hande Ozcan Cetin, et al.
  Pubblicazione: (2025)
• Catheter Ablation in Atrial Fibrillation and Obstructive Sleep Apnea: From Rhythm Control to Risk Reduction
  di: Siddharth Agarwal, et al.
  Pubblicazione: (2025)
• Impact of Anemia on Clinical Outcomes in Atrial Fibrillation Patients on Oral Anticoagulants: A Prognostic Meta‐Analysis
  di: Ahmed Mazen Amin, et al.
  Pubblicazione: (2024)